Yasuhiko Ito, MD PhD is a professor in the Department of Renal Replacement Therapy at Nagoya University in Nagoya, Japan. He is chief of the peritoneal dialysis (PD) unit at Nagoya University Hospital. Nagoya University group sees about 650 patients with PD. In 2010 he developed an educational program called Baxter Scientia Japan at Nagoya University (BSJNU) and has been serving as its chief organizer; more than 2,000 Japanese nephrologists and nurses have attended this program. He is currently contributing to the ISPD Catheter-Related Infections Recommendations: 2016 Update. He received PhD degrees from Nagoya University and Amsterdam University in the Netherlands. His main research interests are the mechanisms of progression of tubulo-interstitial fibrosis in chronic renal injury and peritoneal membrane function and pathogenesis of ultrafiltration failure in PD. He is also involved in clinical trials to optimize PD therapy and to identify biomarkers for EPS. Recently, he reported “Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients,” in JASN. Other works of his research have been published in JASN, Kidney International, Peritoneal Dialysis International, Nephrology Dialysis Transplantation, the Journal of Immunology, and the American Journal of Physiology. His research is supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and CREST Japan Science and Technology Agency, with industry support from Baxter Co., Ltd.